31.01.2014 Views

TiHo Bibliothek elib - Tierärztliche Hochschule Hannover

TiHo Bibliothek elib - Tierärztliche Hochschule Hannover

TiHo Bibliothek elib - Tierärztliche Hochschule Hannover

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Untersuchung des Chemokins MIP-3 β/CCL19<br />

Abstract<br />

Background:<br />

Chemokines are important factors in the mechanism of cell migration and<br />

pathogenesis of central nervous system (CNS) inflammatory reactions. MIP-<br />

3β/CCL19 is one chemokine that may play a major role in this context.<br />

Objective: The aim of this study was to prove the hypothesis that MIP-3β/CCL19 is<br />

involved in the pathogenesis of mononuclear cell migration into the subarachnoid<br />

space of dogs with inflammatory and non-inflammatory CNS diseases such as<br />

steroid-responsive meningitis-arteritis (SRMA) and intervertebral disc disease (IVDD)<br />

and may serve as a valuable biomarker for the progression of the diseases.<br />

Material and methods: This retrospective study analyzed a total of 141 dogs.<br />

Experiments were performed on cerebrospinal fluid (CSF) and peripheral blood (PB)<br />

samples of dogs affected with SRMA during the acute phase (n = 25) as well as<br />

during treatment (n = 26). Dogs with SRMA were compared to dogs with presumed<br />

meningoencephalomyelitis of unknown origin (MUO) receiving no therapy (n = 16)<br />

and with patients receiving prednisolone therapy (n= 11).<br />

A control group with normal cell count consisted of dogs with Idiopathic Epilepsy (IE)<br />

(n= 21) and of healthy dogs (n= 6). Additionally, dogs with IVDD of varying severity<br />

(n= 36) were analyzed. Concentration of MIP-3β/CCL19 in the CSF and serum were<br />

determined by a sandwich ELISA. Migration assays were performed on seven<br />

selected CSF samples using a disposable 96-well chemotaxis chamber (untreated<br />

SRMA n = 3 ; untreated MUO n = 2 ; IVDD n = 2).<br />

Results: MIP-3β/CCL19 was detectable in CSF samples of all dogs. Dogs with<br />

untreated SRMA/MUO displayed pronounced MIP-3β/CCL19 elevations compared to<br />

the control group and patients receiving glucocorticosteroid treatment.<br />

CSF cell count of untreated SRMA/MUO patients was significantly positively<br />

correlated with the MIP-3β/CCL19 CSF concentration. IVDD patients also had<br />

elevated CSF MIP-3β/CCL19 concentration compared to controls, but values were<br />

considerably lower than in inflammatory CNS diseases. Selected CSF samples<br />

including inflammatory and non-inflammatory neurologic diseases displayed<br />

32

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!